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Improvement in fast‑track 
hip and knee arthroplasty: 
a prospective multicentre study 
of 36,935 procedures from 2010 
to 2017
Pelle Baggesgaard Petersen1,12*, Henrik Kehlet1,2, Christoffer Calov Jørgensen1,2,12 & The 
Lundbeck Foundation Centre for Fast‑track Hip and Knee Replacement Collaborative Group*
“Fast‑track” protocols has improved surgical care with a reduction in length of hospital stay (LOS) 
in total hip (THA) and knee arthroplasty (TKA). However, the effects of continuous refinement of 
perioperative care lack detailed assessment. We studied time‑related changes in LOS and morbidity 
after THA and TKA within a collaboration with continuous scientific refinement of perioperative care. 
Prospective multicentre consecutive cohort study between 2010 and 2017 from nine high‑volume 
orthopaedic centres with established fast‑track THA and TKA protocols. Prospective collection of 
comorbidities and complete 90‑day follow‑up from the Danish National Patient Registry and medical 
records. Of 36,935 procedures median age was 69 [62 to 75] years and 58% women. LOS declined from 
three [two to three] days in 2010 to one [one to two] day in 2017. LOS > 4 days due to “medical” or 
“surgical” complications, and “with no recorded morbidity” declined from 4.4 to 2.7%, 1.5 to 0.6%, 
and 3.8 to 1.3%, respectively. 90‑days readmission rate declined from 8.6 to 7.7%. Our multicentre 
study in a socialized healthcare setting was associated with a continuous reduction in LOS and 
morbidity after THA and TKA.
Total hip (THA) and knee (TKA) arthroplasty are common procedures and continuously increasing throughout 
the last  decades1–3, as the population grows older and surgical and perioperative management are refined. How-
ever, although THA and TKA are fairly “safe” procedures, the expenses related to the vast number of procedures 
may strain healthcare economics. In the early 00’s, the introduction of “enhanced recovery after surgery” (ERAS) 
or “fast-track” protocols in THA and TKA drastically improved postoperative  recovery4.
Several European “before” and “after” series of fast-track THA and TKA’s have reported a marked decrease in 
length of stay (LOS) from median five-six to three days, with reduced postoperative morbidity and no increased 
readmission  rates5–7. Consequently, the advantages of a fast-track protocol providing the “best evidence based 
care” may be considerable, especially within a publicly financed healthcare system. Despite this apparent success, 
other large series have shown problems with implementation of most recent evidence-based care principles. In 
this context, a recent UK analysis in more than 400,000 TKA’s investigating the association of national ERAS 
implementation while adjusting for time trends in LOS found no benefits of ERAS implementation, but without 
details on the ERAS  protocols8. . Also, between 2008 and 2016, mean LOS was only reduced by two days from 
mean 5.8 to 3.7 days8. This may be considered somewhat disappointing compared to other studies with mean/
median LOS around of three  days5–7. Additionally, a recent large Canadian regional database study on more than 
200,000 TKAs performed between 2003 and 2016, reported a decrease in LOS from median five to three  days9. 
From the US, reports from large series/databases have shown reductions in LOS from mean about four to three 
 days10,11 and median from three to two  days3, but these studies have several methodological limitations. Thus, 
there has often been a lack of important information on  context12 e.g. organisational factors, the perioperative 
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setting, and completeness and validity of  data13. These factors are important in generalizability of the results 
but also in clinical implementation of the investigated perioperative  setting14. In summary, despite ERAS proto-
cols for THA and TKA have been available and successful for more than a decade, quality assurance data with 
continuous outcome-monitoring on LOS, complications and readmissions are limited, especially with use of 
contemporary evidence-based analgesic techniques, rehabilitation protocols, blood management and optimized 
organisational pathways.
In this context, the Lundbeck Foundation Centre for Fast-track Hip and Knee replacement (www.fthk.dk) was 
established in 2009 as a multicentre collaboration of Danish high-volume ERAS departments, based upon the 
public socialised health care system in Denmark, contributing to about 50% of the Danish THA/TKA production. 
This collaboration was based on the unique monitoring possibilities with several nationwide registries in Den-
mark and furthermore included one to two yearly meetings on outcome monitoring and scientific collaboration 
with more than 170 publications (www.fthk.dk). Consequently, we aimed at investigating time-related changes in 
LOS, cause of LOS > 4 days and 30- and 90-days complete readmission and mortality rates in unselected elective 
unilateral fast-track THA and TKA from this research-based multicentre collaboration with a well-established 
but continuously developing fast-track setup.
Results
We included 36,935 procedures (19,977 (54.1%) THA) in 32,515 patients (Fig. 1) of which 21,524 (58.3%) were 
women and median age was 69 [Q1-Q3; 62–75] years. Median LOS was 2 [1 to 3] days with 2391 (6.5%) having 
a LOS > 4 days. LOS decreased throughout the study period from median three [2 to 3] days (mean 3.0 (± 2.4) 
days) in 2010 to one [1 to 2] day (mean 1.9 (± 1.6) days) in 2017 (Mann–Kendall p = 0.049) (Fig. 2a). Likewise, 
the proportion with LOS > four days decreased from 9.7% in 2010 to 4.6% in 2017 (Mann–Kendall p = 0.004) 
(Fig. 2b). The 30- and 90-day readmission rates decreased insignificantly from 6.1% and 8.6% in 2010 to 5.3% 
and 7.7% in 2017 (p = 0.107 and 0.386), respectively (Fig. 2b).
In-hospital “medical” complications leading to LOS > 4 days did not decline monotonically from 2010 to 
2017 (Mann–Kendall p = 0.108), but with a constant decrease starting in 2014 (4.4% in 2014 to 2.7% in 2017). In 
contrast, the fraction of patients with LOS > 4 days due to “surgical” complications decreased continuously from 
1.5% in 2010 to 0.6% in 2017 (Mann–Kendall p = 0.035). Also, the proportion of patients with no recorded post-
operative morbidity but LOS > 4 days (3.8% in 2010 and 1.3% in 2017) was monotonically decreasing throughout 
the period (Mann–Kendall p = 0.002) (Fig. 2c). For specific causes of LOS > 4 days see Fig. 3 and Supplemental 
Table 1.
THA/TKA in DNPR 
Jan 2010— Aug 2017 
n=41,292 
Primary elective unilateral 
THA/TKA in DNPR  
n=37,944 
Fractures, non-elective procedures or previous surgery on the 
same joint within 90 days. n = 2319 
Severe congenital disorders, infection or cancer n = 172 
Simultaneous or staged  bilateral procedures within 90 days.  
n= 816 
Other (e.g. non-Danish citizens and no standard fast-track proce-
dures. n = 41 
Procedures not in the Lundbeck Centre Database. 
n = 1009 (2.7%) 
Procedures with completed preoperative questionnaire. 
n=36,935 (97.3%) 
Figure 1.  Flowchart of study population. DNPR Danish National Patient Registry, THA total hip arthroplasty, 
TKA total knee arthroplasty.
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Regarding 90-day readmissions “surgical” complications increased slightly from 2.7% in 2010 to 3.6% in 2017 
(p = 0.063), but with a pronounced yearly variation (Fig. 2d). “Medical” complications decreased insignificantly 
from 4.3% in 2010 to 3.2% in 2017 (p = 0.174) (Fig. 2d). Finally, the proportion with suspected but disproven 
morbidity (mostly thromboembolic complications) decreased continuously from 1.6% in 2010 to 0.9% in 2017 
(p = 0.019) (Fig. 2d). See Fig. 4a,b and Supplemental Table 2 for specific causes of 90-day readmissions including 
multiple readmissions.
Overall, there were 112 (0.30%) all-cause deaths at 90 days, without changes throughout the study period 
(p = 0.108) (Fig. 2b). Of the 112 deaths, 72 were “surgically” related (0.19%) after median 18.5 [5.25–38.0] days 
and 27 (0.07%) were not related to surgery and occurring after median 59.5 [39.25–75.50] days. Finally, 13 
(0.04%) patients died at home of unknown causes after median 68 [52–82.25] days (Supplemental Table 3). 
Thus, a worst-case scenario of “surgically” related 90-day mortality results in a rate of 0.23% when including 
deaths of unknown causes.
Median age of patients increased from 68 [61–75] years in 2010 to 70 [62–76] years in 2017, without changes 
in BMI (Fig. 5a). The proportions of patients with age ≥ 80 years, BMI ≥ 35, use of walking aids, preoperative 
potent anticoagulant use, anaemia, psychiatric disorders and pulmonary disease were unchanged throughout 
the period (Fig. 5b). Furthermore, the proportion of patients with two or more of the above-mentioned charac-
teristics remained stable around 22%.
Discussion
For the first time we have documented detailed trends in LOS, readmissions and specific complications within 
a well-established prospective dedicated multicentre fast-track THA and TKA collaboration during a seven-
year period. Our data demonstrated a continuous reduction in LOS from median three to one day (mean 3.0 to 
1.9 days), with fewer patients with LOS > 4 days, and insignificant decreases in 30- and 90-day readmissions, but 
unchanged low “surgically” related mortality about 0.2%.
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Figure 2.  Temporal trends in length of stay (LOS), readmissions and mortality from 2010–2017 in 36,935 
fast-track THA and TKAs. (a) Mean and median LOS, (b) proportion of procedures with LOS > 4 days, 
90-day readmission and mortality rate, (c) proportion of procedures with “surgical”-, “medical”-. and no 
recorded morbidity as reason for LOS > 4 days, (d) readmissions due to “surgical”-, “medical”-, and disproven 
complications. Figure created using R (R: A Language and Environment for Statistical Computing, Version 3.6.1; 
2019) and ggplot (ggplot2: Elegant Graphics for Data Analysis, version 3.3.0, 2016).
4
Vol:.(1234567890)
Scientific Reports |        (2020) 10:21233  | https://doi.org/10.1038/s41598-020-77127-6
www.nature.com/scientificreports/












 






 













 


 




0.0%
0.2%
0.4%
0.6%
0.8%
2010 2011 2012 2013 2014 2015 2016 2017






anaesthetic
fracture w/o trauma
hip dislocation (THA only)
other surgical
periprosthetic infection
wound complication
(a) surgical causes for LOS > 4 days 











 



 












 




  

 











































 
0.0%
0.2%
0.4%
0.6%
0.8%
1.0%
2010 2011 2012 2013 2014 2015 2016 2017














anaemia
cardiovascular
cerebral
dizzyness/OI
falls
gastrointestinal
med/mob
other medical
pain
pulmonary
renal/fluid
sepsis
urological
VTE
(b) medical causes for LOS > 4 days 
Figure 3.  Temporal trends in specific causes for LOS > 4 days in 36,935 fast-track THA and TKAs. (a) “surgical” 
causes; (b) “medical” causes. Figure created using R (R: A Language and Environment for Statistical Computing, 
Version 3.6.1; 2019) and ggplot (ggplot2: Elegant Graphics for Data Analysis, version 3.3.0, 2016).
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Figure 4.  Temporal trends in specific causes for 90-day readmission in 36,935 fast-track THA and TKA. (a) 
“surgical” causes; (b) “medical” causes. Figure created using R (R: A Language and Environment for Statistical 
Computing, Version 3.6.1; 2019) and ggplot (ggplot2: Elegant Graphics for Data Analysis, version 3.3.0, 2016).
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A reduction in LOS (median six to three days) without increase in readmission (4.7% vs 4.6%) after imple-
mentation of a fast-track protocol has been shown in 2014 on 3,000 fast-track procedures from the United 
Kingdom based on NHS  data5. Likewise, a Swedish multicentre cohort study from 2011 to 2015 on 7270 fast-
track procedures from national arthroplasty- and regional patient registers found decreasing LOS from median 
five to three days without changes in 90-day readmission rates after implementation of the fast-track  protocol7. 
From the US, a large study using the Premiere Healthcare claims database demonstrated a reduced LOS of about 
1 day ( from about 3 to 2 days) between 2006 and 2016 depending on degree of adherence to enhanced recovery 
 components15. Also, in 2017 the NSQIP database demonstrated LOS ≤ 1 day in only about 30% of  procedures16. 
However, these results are somewhat difficult to interpret due to limited information on use of post-discharge 
facilities and emergency/short-term readmissions. Recently a study on national implementation of ERAS in 
TKA in the UK using NHS data from 2008 to 2016 found a time-related reduction in LOS from mean 5.8 to 
3.7 days but without additional benefits of the attempted national ERAS  implementation8. However, patients 
with LOS > 15 days were excluded, and there was no clear description of the ERAS protocol, and no analysis of 
reasons for prolonged LOS or complications. However, considering that our participating departments already 
had a decade’s experience with fast-track  protocols17, the continuous reduction in LOS from median three to one 
day and morbidity is encouraging. Thus, our results demonstrate that even years after implementation of fast-
track protocols, a continued focus and refinement of well-established fast-track protocols with implementation 
of e.g. high dose  methylprednisolone18, tranexamic acid, and no routine use of  tourniquets19, drains and urinary 
 catheters20 in combination may lead to further reduction in LOS.
Some of the reduction may be attributed to improved logistics regarding discharge, as suggested by the 
monotonic decrease in the proportion of patients with no mentioned morbidity but a LOS of > 4 days. Potential 
logistic improvement may also have been influenced by the introduction of outpatient THA and TKA surgery 
at two of the collaborating  centres21. However, improved logistics is a key factor in our fast-track protocol and 
the individual components have undergone several scientific evaluations and discussions for implementation at 
the annual scientific meetings. Thus, we believe that improved logistics together with scientific documentation 
of the individual care component (www.fthk.dk) in combination may have contributed to the decreasing LOS.
Despite the absence of monotonic trends in LOS > 4 days due “medical” complications, there was a continu-
ous drop in the number of these from 2014 and onwards. Interestingly, from 2014 the departments introduced 
standard high-dose preoperative methylprednisolone in TKA and increasingly also in THA based upon RCTs 
and the demonstrated improved analgesia, opioid-sparing, reduced nausea and vomiting without safety  issues18.
Figure 5.  Temporal trends of preoperative characteristics of 36,935 fast-track THA and TKA procedures. 
(a) Median age and BMI; (b) preoperative comorbidities; potent anticoagulants: preoperative vitamin-k 
antagonists and direct oral anticoagulant. Figure created using R (R: A Language and Environment for Statistical 
Computing, Version 3.6.1; 2019) and ggplot (ggplot2: Elegant Graphics for Data Analysis, version 3.3.0, 2016).
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A year to year reduction in most specific complications has been demonstrated previously using national 
UK registry data, but with increased occurrence of lower respiratory tract infection (0.54% to 0.84%) and renal 
failure (0.21% to 1.09%) from 2005 to  201422. A recent study from the US using the Premier Database but without 
information on ERAS compliance, also reported a general decreasing complication rates, but increasing occur-
rence of renal insufficiency, potentially attributable to increasing comorbidity or changes in coding  practice3. In 
contrast, we found no increase in renal or pulmonary complications within our data.
Early multidisciplinary instructive  physiotherapy23 and nurse-led centred daily care and discharge is among 
the cornerstones of the early postoperative in-hospital  rehabilitation24. Generally, the use and availability of 
discharge to skilled nursing facilities is rare in Denmark. Thus, a prior publication from the current cohort in 
549 patients ≥ 85 years found that only 7% were discharged to other destinations than home and mainly from 
one  institution25. In contrast, studies from other countries have reported discharge to other destinations than 
own home in 20–50% of  patients2,26.
The minor decline in readmissions combined with the profound decline in in-hospital morbidity leading 
to LOS > 4 days suggest that the continuous effect on the fast-track protocol has primarily been on in-hospi-
tal complications. Importantly, there were only minor yearly fluctuations in post-discharge VTE rates which 
were consistently < 0.2%, confirming previous safety studies of “in-hospital” prophylaxis only in patients with 
LOS ≤ 5 days27. In contrast, there was a tendency towards increased “surgical” readmissions from 2.7% in 2010 
to 3.6% in 2017 as demonstrated by the lack of improvements in hip dislocations and wound complications 
(Fig. 4a, Supplemental Table 2).
We found no changes in 90-day mortality, neither when looking at all-cause or “surgically “related  mortality28, 
while other large national registry studies have found decreasing mortality, although not specifically related to a 
fast-track setup and with limitations in follow-up completeness and time, limiting  comparisons3,5,22,29.
Although we were able to achieve highly detailed information through the combination of complete follow-up 
from a national registry, chart review, and prospective collection of preoperative risk-factors there are some limi-
tations. Thus, the observational design without a control group eliminates the possibility to compare with “con-
ventional” care. However, this was not the aim of our study as we intended to report time trends in perioperative 
outcomes within a clinical and scientific collaboration dedicated to further improvements of perioperative care. 
For such evaluations an observational design may be of considerable  value30. Also, we only included in-hospital 
complications resulting in LOS > 4 days in the analysis, potentially missing minor complications within the first 
four days. The inclusion of patients with multiple procedures within the study period, could also potentially bias 
our  results31, but the same may happen if leaving them  out32. Finally, 2.7% of the performed procedures were 
not registered in the LCDB and consequently excluded from the study. However, a previous investigation on the 
excluded patients did not find any difference in outcome for these patients vs those in  LCDB33. Thus, we believe 
the continuous improvements in our “real-life” multicentre cohort of unselected elective primary THA and TKA 
are generalizable and hopefully may stimulate to continued implementation with adherence to contemporary 
evidence-based fast-track protocols with regular audit of own data. However, we acknowledge that this large 
detailed cohort does not provide patient reported outcomes or surgeon specific data, since we aimed to assess 
whether large-scale improvements could be obtained from the entire care pathway and scientific collaboration 
rather than individual interventions.
In conclusion, our scientific multicentre eight-year collaboration in a socialized healthcare setting was associ-
ated to a continuous reduction in LOS to median one day and lower morbidity after THA and TKA. A continuous 
use and refinement of science-based fast-track protocols may lead to further reduction in LOS and  morbidity23.
Methods
We used an observational study design on a prospectively collected consecutive cohort of unselected primary 
elective unilateral THA and TKA’s from January 2010 to August 2017. The procedures were performed at nine 
dedicated fast-track centres reporting to the Lundbeck Foundation Centre for Fast-track Hip and Knee Replace-
ment database (LCDB)34 and accounting for around 50% of the annual Danish TKA and THA’s. The LCDB 
originally consisted of six orthopaedic centres with an additional three centres joining in 2012, 2013, and 2014, 
respectively. All centres used fast-track protocols focusing on neuraxial anaesthesia, multimodal opioid sparing 
analgesia, in-hospital only thromboprophylaxis if LOS ≤ 5 days, early (< 6 h postoperatively) mobilization, and 
discharge to own home based on functional discharge  criteria20. Minor protocol changes were implemented 
continuously during the collaboration based upon the study results (www.fthk.dk) e.g. perioperative high-dose 
glucocorticoid since  201418, avoidance of tourniquet since  201419, and reduced bladder catherization since 
 201535,36. The reporting of the study follows the “Strengthening the Reporting of Observational studies in Epi-
demiology” (STROBE statement)37 and the “Standards for QUality Improvement Reporting Excellence” (SQUIRE 
2.0)  guideline38. Following Danish law approval from the ethics committee was not required due to the non-
interventional nature of the study. The Danish National Board of Health (3-3013-56/2/EMJO) and the Danish 
Data Protection Agency (RH-2017-132) gave permission to review and store patient records without informed 
consent. The LCDB is registered as an ongoing study registry on ClinicalTrials.gov (NCT01515670). Thus, the 
study was conducted in accordance with relevant guidelines and regulations.
Data on demographics and preoperative comorbidity were prospectively collected by a nurse-assisted patient 
reported questionnaire entered into the  LCDB34. Data on LOS, 90-day readmission and mortality were obtained 
from the Danish National Patient Registry (DNPR) to which reporting is mandatory for all hospitals in Denmark 
securing complete (> 99%) follow-up39. LOS was calculated as postoperative nights in hospital including trans-
fers to other departments and hospitals. Readmissions were defined as unplanned admissions with ≥ 1 night in 
hospital and potentially related to the index surgical procedure. In case of LOS > 4 days, 90-day readmission or 
mortality, discharge summaries were obtained from the departments and scrutinized for reason for prolonged 
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hospitalization, cause of readmission and/or mortality. In case of doubt complete health care records were 
obtained. Readmissions without possible relation to index procedure were excluded (e.g. eye surgery, unre-
lated cancer surgery, planned follow-up on unrelated conditions and other obviously unrelated readmissions). 
Investigation of discharge summaries and health records were done by CJ from Jan 2010 to Sep 2013, and from 
Oct 2013 to Aug 2017 by PBP supervised by CJ. In case of doubt the discharge summary and health records 
were discussed with all authors to obtain agreement on cause and possible relation to index procedure. Based 
on previous work we categorised causes of prolonged admission (LOS > 4 days) and readmission into “surgical” 
and “medical” complications (Table 1), both requiring potential relation to index  procedure33,34. Additionally, 
we investigated potential changes in the proportion of patients with age ≥ 80 years, BMI ≥ 35, use of walking aids, 
preoperative potent anticoagulant use, anaemia, psychiatric disorders and pulmonary disease based on a previous 
investigations finding these variables being associated with “medical”  complications34.
Inclusion criteria were primary unilateral arthroplasty in patients aged ≥ 18 years and with a Danish social 
security number. We excluded non-elective procedures, procedures due to fractures ≤ 90 days, and previous 
THA/TKA ≤ 90 days.
The majority of the current cohort (36,608 procedures) was included in a preliminary study superficially 
describing developments in LOS and 90-day readmissions during the same study  period40. However, that study 
did not explore developments and role of specific complications leading to either prolonged LOS or readmissions, 
nor did it investigate mortality or changes in patient characteristics.
Objectives. The primary objective was to investigate changes in LOS and in-hospital morbidity resulting 
in LOS > 4 days, and 90-day readmissions over time. Secondary outcomes were analyses of specific in-hospital 
complications leading to LOS > 4 days and/or readmission ≤ 90 days and a division into composite outcomes 
of “surgical” and “medical” complications. Finally, all cause and “surgically” related 90-days mortality, 30-days 
readmission rate and changes in preoperative patient characteristics were investigated.
Statistics. All eligible procedures within the study period were included and no pre-study power calculation 
was performed. Continuous data are presented as mean (SD) or median [IQR] and compared using Student’s 
t-test or Mann–Whitney U test as appropriate. Normality was assed using histograms and q–q plots. Categori-
cal data are reported as actual number (%) and compared using chi-square or Fisher’s exact test as appropriate. 
When reporting readmission rates, “medical” and “surgical” morbidity rates we included only the first readmis-
sion. When reporting specific types of morbidity all readmissions were included. To investigate potential mono-
tonic trends in proportions over time we used the Mann–Kendall test. We considered p < 0.05 as statistically 
significant. Initial data analysis was done using SPSS v.25 (IBM Corp, Armonk, NY, USA) while Mann–Kendall 
Analysis and plots were made in R (R Core Team, 2019) using the “Kendall” (Mcleod, 2011) and “ggplot2” 
(Wickham, 2016) packages.
Data availability
Limited data (deidentified preoperative questionnaire on comorbidities) is available for sharing upon reasonable 
request after approval from the Danish Data Protection Agency, due to data retrieval of the majority of variables 
from third parties.
Received: 12 August 2020; Accepted: 3 November 2020
Table 1.  Classification of “medical” versus “surgical” complications.
“Medical” complications “Surgical” complications
Sepsis Anaesthetic complication
Cardiac Prosthetic infection
Gastrointestinal Hip dislocation
Anaemia Fractures without trauma
Venous thromboembolism Wound complications
Medication/mobilization Revision surgery
Fall Knee manipulation under anaesthesia
Orthostatic intolerance/dizziness
Urological
Renal
Pulmonary
Cerebral
Pain
Other
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